Advertisement

Low incidence of arrhythmic syncope and pacemaker implantation in older patients with bifascicular block and implantable cardiac monitor

Published:November 01, 2022DOI:https://doi.org/10.1016/j.ijcard.2022.10.171

      Highlights

      • What is the incidence of a Class I PM implantation in patients with syncope and bifascicular block (BFB) who receive an ICM?
      • Among patients with BFB and ICM, 1/3 experienced syncope at follow-up, but only a minority of these were arrhythmic and received a PM implantation.
      • Age was the strongest factor associated with PM implantation with risk being >4 times higher in patients ≥75 years.
      • The mechanism of syncope in old patients with BFB is heterogeneous, being non-arrhythmic in most of them. An earlier direct PM implantation, before ECG documentation of the mechanism, should be discouraged because of the high risk of ineffectiveness.
      • Our findings support a multiparametric approach to these patients which includes a careful assessment of non-cardiac causes of syncope.

      Abstract

      Background

      In patients with unexplained syncope, bifascicular block (BFB) is considered associated with syncope due to either heart block or sinus arrest. Immediate or delayed pacemaker (PM) implantation after ECG documentation of syncopal recurrence by means of implantable cardiac monitors (ICM) is still debated. We aimed to assess the incidence of recurrent syncope and guideline-based PM implantation in patients with syncope and BFB implanted with ICM.

      Methods

      Consecutive patients with syncope and BFB followed at two tertiary care syncope units and implanted with ICM from 2012 to 2020 were retrospectively reviewed. Only patients with ≥2 clinical visits and ≥ 18 years of age were included. Incidence of a Class I indication for PM implantation was the primary outcome.

      Results

      Of 635 syncope patients implanted with an ICM, 55 (8.7%) had a BFB and were included. Median age at implantation was 75 [interquartile range, IQR:64–81] years, and 28(49.1%) were women. At 26 [IQR:12–41] months follow-up, 20 (36.3%,16.3%/year) patients experienced syncope: in 6(10.9%) patients syncope was classified ‘arrhythmic’ with a higher prevalence in older individuals (p = 0.048). PM implantation (N = 14,25.5%) was more frequent in patients ≥75 years (p = 0.024). At survival analysis, patients ≥75 years were at highest risk of arrhythmic syncope and guideline directed PM implantation (Hazard Ratio: 4.5, 95% Confidence Intervals 1.5–13.3).

      Conclusions

      Most older patients with syncope who received an ICM did not have events during follow-up. One-in-three experienced syncope, and an even smaller number had an arrhythmic syncope with indication for PM implantation. Older age was strongly associated with PM implantation.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Santini M.
        • et al.
        Prevention of syncope through permanent cardiac pacing in patients with bifascicular block and syncope of unexplained origin: the PRESS study.
        Circ. Arrhythm. Electrophysiol. 2013; 6: 101-107
        • Goldberger Z.D.
        • et al.
        ACC/AHA/HRS versus ESC guidelines for the diagnosis and Management of Syncope: JACC guideline comparison.
        J. Am. Coll. Cardiol. 2019; 74: 2410-2423
        • Brignole M.
        • et al.
        2018 ESC guidelines for the diagnosis and management of syncope.
        Eur. Heart J. 2018; 39: 1883-1948
        • Kobza R.
        • et al.
        Twelve-lead electrocardiography in the young: physiologic and pathologic abnormalities.
        Heart Rhythm. 2012; 9: 2018-2022
        • Brignole M.
        • et al.
        Low-blood pressure phenotype underpins the tendency to reflex syncope.
        J. Hypertens. 2021; 39: 1319-1325
        • Brignole M.
        • Rivasi G.
        New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope.
        Heart. 2021; 107: 864-873
        • Curtis A.B.
        • Karki R.
        • Hattoum A.
        • Sharma U.C.
        Arrhythmias in patients ≥80 years of age: pathophysiology, management, and outcomes.
        J. Am. Coll. Cardiol. 2018; 71: 2041-2057
        • Shan R.
        • et al.
        Prevalence and risk factors of atrioventricular block among 15 million Chinese health examination participants in 2018: a nation-wide cross-sectional study.
        BMC Cardiovasc. Disord. 2021; 21: 289
        • Ostrander L.D.J.
        • Brandt R.L.
        • Kjelsberg M.O.
        • Epstein F.H.
        Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan.
        Circulation. 1965; 31: 888-898
        • Task Force for the Diagnosis and Management of Syncope
        • et al.
        Guidelines for the diagnosis and management of syncope (version 2009).
        Eur. Heart J. 2009; 30: 2631-2671
        • Glikson M.
        • et al.
        2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy.
        Eur. Heart J. 2021; 42: 3427-3520
        • Torabi P.
        • et al.
        Early and late-onset syncope: insight into mechanisms.
        Eur. Heart J. 2022; ehac017https://doi.org/10.1093/eurheartj/ehac017
        • Sardu C.
        • et al.
        Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: The CARVAS study.
        Diabetes Res. Clin. Pract. 2019; 151: 152-162
        • Sheldon R.
        • et al.
        Randomized pragmatic trial of pacemaker versus implantable cardiac monitor in syncope and bifascicular block.
        JACC Clin. Electrophysiol. 2022; 8: 239-248
        • Brignole M.
        • et al.
        Mechanism of syncope in patients with bundle branch block and negative electrophysiological test.
        Circulation. 2001; 104: 2045-2050
        • Del Rosso A.
        • Alboni P.
        • Brignole M.
        • Menozzi C.
        • Raviele A.
        Relation of clinical presentation of syncope to the age of patients.
        Am. J. Cardiol. 2005; 96: 1431-1435
        • Sheldon R.S.
        • et al.
        Electrophysiology studies for predicting atrioventricular block in patients with syncope: a systematic review and meta-analysis.
        Heart Rhythm. 2021; 18: 1310-1317
        • Sardu C.
        • et al.
        ELectrophysiological mechanisms underlying the inhibitory CArdiac syncope without asystolic significant pause: therapeutic and prognostic implications. The ELICA randomized trial.
        Medicine. 2018; 97e11757
        • Sheldon R.
        • et al.
        Randomized pragmatic trial of pacemaker versus implantable cardiac monitor in syncope and bifascicular block.
        JACC Clin. Electrophysiol. 2022; 8: 239-248
        • Eriksson P.
        • Hansson P.O.
        • Eriksson H.
        • Dellborg M.
        Bundle-branch block in a general male population: the study of men born 1913.
        Circulation. 1998; 98: 2494-2500
        • Xiao X.
        • et al.
        Prediction of pacemaker requirement in patients with unexplained syncope: the DROP score.
        Heart Lung. Circ. 2022; 31: 999-1005
        • Palmisano P.
        • et al.
        Management of older patients with unexplained, recurrent, traumatic syncope and bifascicular block: implantable loop recorder versus empiric pacemaker implantation—results of a propensity-matched analysis.
        Heart Rhythm. 2022; https://doi.org/10.1016/j.hrthm.2022.05.023
        • Brignole M.
        • et al.
        Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope.
        Eur. Heart J. 2006; 27: 1085-1092